The effect of high thoracic epidural anesthesia on systolic and diastolic left ventricular function in patients with

Christoph Schmidt1, Frank Hinder, Hugo Van Aken

  • 1Departments of *Anesthesiology and Surgical Intensive-Care Medicine, †Cardiology, and ‡Chest, Heart, and Vascular Surgery, University of Münster Hospital, Germany.

Insights

High thoracic epidural anesthesia (HTEA) improves cardiac function in coronary artery disease patients by enhancing diastolic function, not systolic function. This intervention shows promise for managing myocardial ischemia.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Cardiovascular Physiology

Background:

  • Coronary artery disease involves sympathetic nervous system activation leading to vasoconstriction and myocardial ischemia.
  • Alpha-adrenergic receptor activation contributes to epicardial and microvascular constriction.
  • High thoracic epidural anesthesia (HTEA) can attenuate ischemia by inhibiting sympathetic activity, but its effect on left ventricular (LV) function is debated.

Purpose of the Study:

  • To investigate the impact of HTEA on both systolic and diastolic left ventricular (LV) function.
  • To clarify whether HTEA improves global LV function, specifically assessing its effects on diastolic and systolic parameters.

Main Methods:

  • Thirty-seven patients undergoing coronary artery surgery received HTEA while awake.
  • Echocardiographic and hemodynamic measurements, including myocardial performance index (MPI), fractional area change, and intraventricular flow propagation velocity (Vp), were recorded before and after HTEA.
  • LV function was serially quantified using combined systolic/diastolic and specific systolic or diastolic variables.

Main Results:

  • HTEA significantly improved diastolic LV function, evidenced by an increase in Vp (45.1 to 53.8 cm/s; P < 0.001).
  • Indices of systolic function showed no significant change after HTEA.
  • The overall myocardial performance index (MPI) improved significantly (0.51 to 0.35; P < 0.001), driven by enhanced diastolic characteristics.

Conclusions:

  • HTEA administration leads to a significant improvement in diastolic left ventricular function.
  • The observed improvement in global cardiac function with HTEA is primarily attributed to enhanced diastolic characteristics, not systolic performance.

Related Concept Videos

Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...